---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-076349"
form_type: "8-K"
ticker: null
cik: "0001633070"
company_name: "Axcella Health Inc."
filed_at: "2023-06-29T23:59:59+00:00"
generated_at: "2026-06-13T14:54:39.594321+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Axcella Health receives Nasdaq delisting notice for bid price non-compliance; CMO resigns

## Summary
- Nasdaq notified Axcella of delisting for non-compliance with $1.00 bid price; delisting set for July 10, 2023 unless hearing requested.
- Company plans to request hearing to stay delisting; stock remains listed pending outcome.
- Previous 180-day grace period to regain $1.00 bid price ended June 28, 2023 without compliance.
- Chief Medical Officer Margaret Koziel resigned effective June 23, 2023; will consult on restructuring.

## SEC filing metadata
- accession: 0001104659-23-076349
- form_type: 8-K
- cik: 0001633070
- company_name: Axcella Health Inc.
- filed_at: 2023-06-29T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01, 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1633070/000110465923076349/0001104659-23-076349-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1633070/000110465923076349/tm2320233d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-076349
- JSON: https://secwatch.observer/filing/0001104659-23-076349.json
- Plain text: https://secwatch.observer/filing/0001104659-23-076349.txt

## Key facts
- Listing & Compliance Notices
  Axcella Health Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5450(a)(1)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1)
  source text: June 29, 2023, Axcella Health Inc., (the “Company”) was notified by the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that, based upon the Company’s non-compliance with the $1.00 bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1) as of June 28, 2023, the Company would be delisted at the opening of business on July 10, 2023 unless the Company timely requests a hearing before a Nasdaq Hearings Panel (the “Panel”) to address the deficiencies and present a plan to regain compliance. The Company plans to timely request a hearing before the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1633070/000110465923076349/0001104659-23-076349-index.htm
- Executive change
  Margaret Koziel resigned as Senior Vice President and Chief Medical Officer at Axcella Health Inc..
  - Action: resigned
  - Role: Senior Vice President and Chief Medical Officer
  source text: On June 23, 2023, Margaret Koziel, M.D., who has served as the Company’s Senior Vice President and Chief Medical Officer, notified the Company of her resignation from the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1633070/000110465923076349/0001104659-23-076349-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.